4.1 Innate & Adaptive Immunity Mechanisms
Key Takeaways
- Innate immunity is rapid, germline-encoded, and non-specific; adaptive immunity is slower initially, antigen-specific, and generates memory.
- Complement converges on C3; MAC (C5b–C9) lyses cells, while C3a/C5a anaphylatoxins recruit inflammation and C3b opsonizes.
- MHC I presents cytosolic peptides to CD8 T cells; MHC II presents extracellular peptides to CD4 T cells after endosomal processing.
- Antibody classes divide labor: IgM (primary/pentamer), IgG (secondary/opsonization/placenta), IgA (mucosal), IgE (mast cells/parasites), IgD (B-cell receptor).
- High-yield cytokines map to function: IL-1/IL-6/TNF-α (acute inflammation), IL-2 (T-cell growth), IL-4/IL-5 (Th2/IgE/eosinophils), IL-12/IFN-γ (Th1), IL-10/TGF-β (regulation).
Innate vs Adaptive Immunity: The Core Distinction
The immune system is organized into two cooperating arms. Innate immunity provides immediate defense using germline-encoded recognition molecules that detect conserved microbial patterns. It does not generate lasting antigen-specific memory in the classical lymphocyte sense, but it shapes adaptive responses through antigen presentation and cytokines. Adaptive immunity uses clonally rearranged antigen receptors on T and B lymphocytes, expands the matching clones, and stores memory that accelerates subsequent encounters.
| Feature | Innate | Adaptive |
|---|---|---|
| Speed | Minutes to hours | Days for primary; hours–days for secondary |
| Specificity | Pattern recognition (broad) | Antigen-specific clones |
| Memory | Limited/nonclassical | Robust (memory T/B) |
| Key cells | Barriers, neutrophils, macros, NK, dendritic cells | T cells, B cells, plasma cells |
| Key molecules | Complement, PRRs, IFN, acute-phase proteins | TCR, BCR, antibodies, cytokines |
CBSE vignettes often ask which arm fails first (neutropenia → bacterial/fungal pyogenic infections) versus which fails later or with opportunistic pathogens (T-cell defects → viruses, fungi, Pneumocystis).
Physical, Chemical, and Microbiologic Barriers
Before leukocytes engage, anatomic barriers limit entry. Intact skin (keratin, dry surface, antimicrobial peptides such as defensins) and mucosa (tight junctions, mucus, ciliary clearance) form the first line. Chemical barriers include gastric acid, lysozyme in tears and saliva (cleaves peptidoglycan), and secretory IgA at mucosal surfaces once adaptive immunity is engaged. Commensal flora occupy niches and compete with pathogens—disruption by broad-spectrum antibiotics is a classic setup for Clostridioides difficile or mucosal candidiasis.
Complement: Three Paths, One C3 Hub
Complement is a cascade of plasma proteins that opsonizes microbes, recruits inflammation, and can directly lyse susceptible membranes. All three activation routes converge on C3 convertase and then on a shared terminal pathway.
| Pathway | Trigger | Early components (high-yield) |
|---|---|---|
| Classical | Antigen–antibody (IgM or IgG) binds C1q | C1 → C4 + C2 → C4b2a (C3 convertase) |
| Alternative | Spontaneous C3 tickover on pathogen surfaces; amplified by factor B/D | C3bBb (C3 convertase); properdin stabilizes |
| Lectin | Mannose-binding lectin (MBL) binds microbial sugars | MBL-associated proteases cleave C4/C2 like classical |
After C3 cleavage:
- C3b is the major opsonin (recognized by CR1 and related receptors on phagocytes).
- C3a and C5a are anaphylatoxins: they degranulate mast cells and recruit neutrophils (C5a is especially potent chemotactically).
- Terminal pathway: C5b assembles C6–C9 into the membrane attack complex (MAC), a pore that lyses Neisseria and other susceptible organisms. Deficiencies of C5–C9 produce recurrent Neisseria infections—a classic Step-style association.
Regulatory molecules prevent host damage: C1 esterase inhibitor (C1-INH) limits classical/lectin initiation and bradykinin pathways; DAF (CD55) and CD59 protect host cells from MAC. Loss of GPI-anchored DAF/CD59 underlies paroxysmal nocturnal hemoglobinuria (PNH) with complement-mediated hemolysis—more hematology than pure immunology, but the mechanism links back to unregulated MAC/C3 attack.
Pattern Recognition: PRRs and TLRs
Innate cells sense microbes through pattern recognition receptors (PRRs) that detect pathogen-associated molecular patterns (PAMPs) and damage-associated molecular patterns (DAMPs). Toll-like receptors (TLRs) are the most tested PRR family.
| TLR (examples) | Ligand theme | Location |
|---|---|---|
| TLR4 | LPS (Gram-negative) with MD-2/CD14 | Surface |
| TLR2 (with TLR1/6) | Peptidoglycan, lipopeptides | Surface |
| TLR3 | dsRNA (viral) | Endosome |
| TLR7/8 | ssRNA | Endosome |
| TLR9 | Unmethylated CpG DNA | Endosome |
Signaling through MyD88-dependent (most TLRs) or TRIF-dependent (TLR3, some TLR4) pathways activates NF-κB and IRFs, driving inflammatory cytokines and type I interferons. Dendritic cells integrate PRR signals with antigen uptake to mature and migrate to lymph nodes—bridging innate recognition to adaptive priming.
Cellular Innate Effectors: Neutrophils, Macrophages, NK Cells
Neutrophils arrive first via selectin rolling, integrin firm adhesion, and chemokine-guided extravasation. They phagocytose opsonized microbes and kill via NADPH oxidase–generated ROS (oxidative burst), myeloperoxidase, and granule proteases. Defective oxidative burst defines chronic granulomatous disease (covered with immunodeficiency).
Macrophages are longer-lived tissue residents and recruited monocytes. They phagocytose, present antigen on MHC II, and polarize: M1-like (IFN-γ driven, microbicidal, IL-12) versus M2-like (IL-4/IL-13, repair, IL-10). Natural killer (NK) cells kill virus-infected and tumor cells missing MHC I (“missing self”) via perforin/granzyme and ADCC through CD16 (FcγRIII) recognizing IgG-coated targets. NK cells are also activated by IL-12 and IFN-α/β and produce IFN-γ that feeds back to macrophages.
MHC Restriction and Antigen Presentation
Adaptive T-cell recognition is MHC-restricted: the TCR sees peptide nested in an MHC groove.
| Feature | MHC I | MHC II |
|---|---|---|
| Structure | Heavy chain + β2-microglobulin | α and β chains |
| Expression | All nucleated cells | APCs (DC, macros, B cells) |
| Peptide source | Cytosolic (viral, tumor, self) | Extracellular/vesicular |
| Processing | Proteasome → TAP → ER loading | Endosomal proteases; CLIP/HLA-DM exchange |
| Presents to | CD8 cytotoxic T cells | CD4 helper T cells |
| Outcome | Kill infected cell | Help B cells, macros, CD8s |
CD8 T cells recognize MHC I–peptide, release perforin/granzyme, and express FasL to induce apoptosis. CD4 T cells differentiate into helper subsets: Th1 (IFN-γ, IL-12 driven—activate macros against intracellular pathogens), Th2 (IL-4, IL-5, IL-13—helminth/allergy/IgE), Th17 (IL-17—neutrophil recruitment at barriers; excess → autoimmunity), and Treg (FoxP3, IL-10, TGF-β—peripheral tolerance).
B-Cell Activation and Antibody Effector Functions
Naive B cells express surface IgM/IgD. Antigen binding cross-links the BCR; full responses to protein antigens usually require T-dependent help: B cells present antigen on MHC II to CD4 Tfh cells, receive CD40L–CD40 and cytokine signals, then undergo class switching, affinity maturation (somatic hypermutation in germinal centers), and differentiation into plasma cells and memory B cells. T-independent antigens (repetitive polysaccharides) mainly produce IgM without strong memory—why pure polysaccharide vaccines may be less immunogenic in infants, prompting conjugate designs that recruit T help.
Antibody classes (isotypes)
| Isotype | Structure/location | High-yield functions |
|---|---|---|
| IgM | Pentamer (secreted); first isotype | Primary response; strong complement fixation; BCR as monomer |
| IgG | Monomer; serum dominant | Secondary response; opsonization; ADCC; neutralizes toxins/viruses; crosses placenta (neonatal immunity) |
| IgA | Dimer at mucosa (secretory component) | Mucosal immunity; breast milk; neutralizes at surfaces |
| IgE | Monomer; bound to FcεRI on mast cells/basophils | Type I hypersensitivity; defense against helminths |
| IgD | Surface on naive B cells | BCR co-receptor role; little secreted function tested |
Primary vs secondary humoral response
The primary response has a lag of days, peaks with IgM then class-switched isotypes, and generates memory. The secondary (anamnestic) response is faster, higher-titer, and dominated by high-affinity IgG (or appropriate isotype at the site) because memory B cells and affinity-matured clones expand rapidly. Serologic timelines (e.g., IgM then IgG after infection or immunization) are common vignette anchors.
High-Yield Cytokines
Cytokines are short-range messengers; map each to producer/context and effect rather than memorizing isolated lists.
| Cytokine | Core role (mechanism-first) |
|---|---|
| IL-1 | Endogenous pyrogen; endothelial activation; acute inflammation (with TNF) |
| IL-2 | T-cell growth/proliferation factor; supports effector and Treg niches |
| IL-4 | Drives Th2; class switch to IgE; alternative macrophage activation |
| IL-5 | Eosinophil growth/activation; IgA support |
| IL-6 | Acute-phase response (CRP, hepcidin); fever; plasma-cell survival |
| IL-10 | Anti-inflammatory; inhibits APC/Th1 overdrive |
| IL-12 | Induces Th1 and NK IFN-γ production |
| IFN-γ | Macrophage activation; MHC upregulation; Th1 signature |
| TNF-α | Vascular leak, leukocyte recruitment; septic shock mediator; cachexia |
| TGF-β | Wound healing/fibrosis; Treg support; IgA class switch context |
Type I interferons (IFN-α/β) are antiviral: induce antiviral state in neighboring cells and enhance MHC I and NK activity. On Step-style items, IL-12/IFN-γ axis defects cause mycobacterial susceptibility; excess TNF drives inflammatory pathology treatable with anti-TNF agents (pharmacology section).
Integrated Mechanism Snapshot
A microbe breaches a barrier → PRRs on tissue macrophages/DCs fire → IL-1/IL-6/TNF and chemokines recruit neutrophils → complement opsonizes (C3b) and attracts cells (C5a) → DCs carry antigen to nodes → MHC II–CD4 and cross-presentation MHC I–CD8 prime adaptive effectors → B cells produce isotype-switched antibodies with T help → memory accelerates the next hit. CBSE questions rarely ask for isolated facts; they present a defect or vignette and expect you to name the failed step in this chain.
A patient has recurrent Neisseria bacteremia. Total hemolytic complement activity is low, and terminal complement components are absent. Which effector structure is primarily missing?
A virus replicates in the cytosol of an epithelial cell. Which antigen-presentation pathway most directly alerts CD8 T cells to kill that cell?
After a booster vaccine, serum shows a rapid rise in high-affinity IgG. Which process best explains this secondary response pattern?